Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from the pivotal ...
The Star Worldwide (English) on MSN
How Kenya’s HIV Care System Is Buckling Under Donor Withdrawal
Over the past decade, Kenya has been a global beacon, celebrated for achieving near-universal access to life-saving HIV treatment ...
On 13 November 2025, Merck Sharp & Dohme LLC initiated a study is to learn if people who receive patritumab deruxtecan (also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback